Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters A version ofContinue Reading